- Featured Product
- KD/KO Validated
TIA1 Polyklonaler Antikörper
TIA1 Polyklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), IP, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte und mehr (1)
Anwendung
WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ChIP, RIP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 12133-2-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | COLO 320-Zellen, Jurkat-Zellen, Mausmilzgewebe, Maus-Thymusgewebe, Raji-Zellen |
Erfolgreiche IP | Jurkat-Zellen |
Erfolgreiche Detektion in IHC | humanes Lymphomgewebe, Maushirngewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in IF/ICC | L02-Zellen, HeLa-Zellen, HepG2-Zellen |
Erfolgreiche Detektion in FC (Intra) | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunhistochemie (IHC) | IHC : 1:50-1:500 |
Immunfluoreszenz (IF)/ICC | IF/ICC : 1:50-1:500 |
Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 4 publications below |
WB | See 32 publications below |
IHC | See 3 publications below |
IF | See 32 publications below |
CoIP | See 1 publications below |
ChIP | See 1 publications below |
RIP | See 1 publications below |
Produktinformation
12133-2-AP bindet in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ChIP, RIP, ELISA TIA1 und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Huhn, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | TIA1 fusion protein Ag2778 |
Vollständiger Name | TIA1 cytotoxic granule-associated RNA binding protein |
Berechnetes Molekulargewicht | 214 aa, 24 kDa, 43 kDa |
Beobachtetes Molekulargewicht | ~40 kDa |
GenBank-Zugangsnummer | BC015944 |
Gene symbol | TIA1 |
Gene ID (NCBI) | 7072 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
TIA1, also named as p40-TIA-1, is involved in alternative pre-RNA splicing and regulation of mRNA translation by binding to AU-rich elements (AREs) located in mRNA 3' untranslated regions (3' UTRs). It possesses nucleolytic activity against cytotoxic lymphocyte target cells. TIA1 may be involved in apoptosis. Two isoforms of this protein exist - 41kDa and 42kDa. one of these was a missense variant (P362L) in TIA1. Similar to the ALS-related disease proteins TDP-43, hnRNPA1, and FUS, TIA1 is an RNA-binding protein containing a prionlike LCD and assembles into membrane-less organelles, including SGs. Postmortem neuropathology of five TIA1mutations carriers showed a consistent pathological signature with numerous round, hyaline, TAR DNA-binding protein 43 (TDP-43)-positive inclusions.TIA1mutations significantly increased the propensity of TIA1 protein to undergo phase transition. In live cells,TIA1mutations delayed stress granule (SG) disassembly and promoted the accumulation of non-dynamic SGs that harbored TDP-43. Moreover, TDP-43 in SGs became less mobile and insoluble.
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for TIA1 antibody 12133-2-AP | Protokoll herunterladen |
IHC protocol for TIA1 antibody 12133-2-AP | Protokoll herunterladen |
IF protocol for TIA1 antibody 12133-2-AP | Protokoll herunterladen |
IP protocol for TIA1 antibody 12133-2-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Cell In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
| ||
Cell Res Predicting dynamic cellular protein-RNA interactions by deep learning using in vivo RNA structures. | ||
Nat Struct Mol Biol TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. | ||
Neuron TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. | ||
Nat Commun Cellular stress alters 3'UTR landscape through alternative polyadenylation and isoform-specific degradation. | ||
Brain Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia |
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH haibo (Verified Customer) (09-28-2020) | Western blotting was good. But can not see clear granule signal even after treatment by IF. The cells used were fibroblasts.
|
FH Manohar (Verified Customer) (09-23-2020) | Used 1% Milk for blocking
|
FH Joshua (Verified Customer) (12-28-2019) | PANC1 cells fixed in 4% paraformaldehyde and stained overnight at 4C. Bright staining, mix of nuclear and stress granule localization as expected.
|
FH Joshua (Verified Customer) (12-12-2018) | We found acetone fixation (20 min in 100% acetone at -20C) worked better than paraformaldehyde.
|